Oral Griseofulvin and topical 1%Clotrimazole cream , are they still effective and safe?
Phase 3
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2019/04/018461
- Lead Sponsor
- ashutosh pal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
griseofulvin naive
Exclusion Criteria
pregnancy, lactation, systemic illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete clearance that is no active lesion with negative KOH test. <br/ ><br>Partial clearance which is reduction in symptoms with or without positive KOH. <br/ ><br>Non clearance is no reduction in symptoms and negative KOH even after appropriate duration of therapyTimepoint: week 0,2,4,6,8
- Secondary Outcome Measures
Name Time Method Adverse events ranging from mild headache, urticaria and nausea to hepatotoxicity and Steven Johnson syndromeTimepoint: week 2,4,6,8